Skip to main content
Premium Trial:

Request an Annual Quote

Promega's Nano-Glo Dual-Luciferase Reporter Assay

Promega has launched the new Nano-Glo Dual-Luciferase Reporter (NanoDLR) Assay, a two-reporter system that incorporates NanoLuc luciferase technology, providing increased data quality and greater sensitivity for biologically complex applications. The NanoDLR assay allows researchers to measure NanoLuc and firefly luciferases together and its chemistry provides improved reagent stability over time, giving more consistent results and eliminating the need to freeze reagents.

Along with the assay, NanoLuc and firefly luciferase plasmids are also available. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.